Free Live Webinar
How Biotech Companies Secure Capital: What Investors and Pharma Actually Want to See
Biologics' experienced team of industry experts and former FDA officials brings deep regulatory knowledge and expertise. Precise X Med helps biotech make their technology investible and Pharma ready. We are thrilled to partner with Conscious Capital, which supports private companies in healthcare and life sciences, and family offices that leverage their resources, beyond capital, and network to foster company growth.
60 minutes, including Q&A Zoom link sent to registrants
Register NowPresented in partnership with
Conscious Capital
Healthcare & Life Sciences
Choose Your Date
Topics of Discussion
How Preparation Signals Investment Worthiness
- —How U.S. investors determine fit and assess readiness very quickly
- —How U.S. investors assess risk in non-obvious ways
- —The most common gaps that derail deals before they start
How to De-Risk Your Company — Three Levers That Move Investors
- —Pharma partnerships: why a letter of intent or co-development agreement changes your valuation conversation entirely
- —Non-dilutive funding: how EIC Accelerator, Horizon Europe, and national grants reduce investor risk and extend runway without giving up equity
- —Clinical plan: why every developing biotech needs a credible clinical development roadmap
Bridging the Gap Between U.S. Investors and European Biotech Companies
- —Why investing in Europe is compelling now
- —How staying in alignment with true growth attracts U.S. investors
Speakers
Dr. Neta Kela, PhD
Commercialization Partner, Biologics – PXM
Robert Smith
Founder and CEO, Conscious Capital
Reserve Your Spot
This webinar is free. Complete the form below and we will send your Zoom link.